VALENS SEMICONDUCTOR LTD (VLN)

IL0011796880 - Common Stock

1.96  +0.12 (+6.52%)

Fundamental Rating

3

Overall VLN gets a fundamental rating of 3 out of 10. We evaluated VLN against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for VLN as it has an excellent financial health rating, but there are worries on the profitability. VLN is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year VLN has reported negative net income.
VLN had a positive operating cash flow in the past year.
In the past 5 years VLN always reported negative net income.
VLN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

VLN has a worse Return On Assets (-16.28%) than 77.78% of its industry peers.
With a Return On Equity value of -18.64%, VLN is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -16.28%
ROE -18.64%
ROIC N/A
ROA(3y)-12.71%
ROA(5y)-18.04%
ROE(3y)-14.35%
ROE(5y)-20.82%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

VLN has a Gross Margin of 60.44%. This is amongst the best in the industry. VLN outperforms 85.19% of its industry peers.
In the last couple of years the Gross Margin of VLN has declined.
The Profit Margin and Operating Margin are not available for VLN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.48%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

VLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VLN has been increased compared to 1 year ago.
VLN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

VLN has an Altman-Z score of 4.37. This indicates that VLN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of VLN (4.37) is comparable to the rest of the industry.
VLN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.37
ROIC/WACCN/A
WACC14.51%

2.3 Liquidity

VLN has a Current Ratio of 9.71. This indicates that VLN is financially healthy and has no problem in meeting its short term obligations.
VLN's Current ratio of 9.71 is amongst the best of the industry. VLN outperforms 95.37% of its industry peers.
A Quick Ratio of 8.85 indicates that VLN has no problem at all paying its short term obligations.
VLN's Quick ratio of 8.85 is amongst the best of the industry. VLN outperforms 97.22% of its industry peers.
Industry RankSector Rank
Current Ratio 9.71
Quick Ratio 8.85

2

3. Growth

3.1 Past

VLN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.00%, which is quite impressive.
VLN shows a decrease in Revenue. In the last year, the revenue decreased by -7.23%.
Measured over the past years, VLN shows a quite strong growth in Revenue. The Revenue has been growing by 13.93% on average per year.
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.5%
Revenue 1Y (TTM)-7.23%
Revenue growth 3Y13.93%
Revenue growth 5YN/A
Sales Q2Q%13.21%

3.2 Future

Based on estimates for the next years, VLN will show a very negative growth in Earnings Per Share. The EPS will decrease by -17.35% on average per year.
The Revenue is expected to decrease by -2.64% on average over the next years.
EPS Next Y-233.3%
EPS Next 2Y-65.14%
EPS Next 3Y-17.35%
EPS Next 5YN/A
Revenue Next Year-31.78%
Revenue Next 2Y-10.45%
Revenue Next 3Y-2.64%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VLN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VLN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as VLN's earnings are expected to decrease with -17.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-65.14%
EPS Next 3Y-17.35%

0

5. Dividend

5.1 Amount

No dividends for VLN!.
Industry RankSector Rank
Dividend Yield N/A

VALENS SEMICONDUCTOR LTD

NYSE:VLN (11/29/2024, 11:11:56 AM)

1.96

+0.12 (+6.52%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap208.50M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.28%
ROE -18.64%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 60.44%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 9.71
Quick Ratio 8.85
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-233.3%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-7.23%
Revenue growth 3Y13.93%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y